ICYMI: Drug Topics September/October 2024 Issue

FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?

Two posted presented at the American Heart Association’s 2024 Scientific Sessions explored empagliflozin among patients with type 2 diabetes and cardiovascular risk.

October 31st 2024

Real-Time Pharmacist Feedback Improves Heart Failure Medication Management | AHA 2024

Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.

Lauren Biscaldi, MS, Managing Editor

Keeping the Focus on Community Pharmacy Advocacy at the State Level

Results of a study at the Veterans Health Administration found that feedback and education led to better medication outcomes for patients.

September 23rd 2024

Eating Problems, Diabetes Distress Associated with Worse Time-in-Range | AHA 2024

Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.

Over Half of US Population Concerned About Prescription Drug Access, Prices

Patients with type 2 diabetes who had eating problems and higher levels of diabetes distress had worse time-in-range.

Evaluating Empagliflozin’s Impact on Cardiovascular Outcomes in Patients with T2D | AHA 2024

Wolters Kluwer Health conducted a survey of just over 1000 respondents to get US adults’ feelings about notable trends in the pharmacy industry.

Related Content

FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?

Two posted presented at the American Heart Association’s 2024 Scientific Sessions explored empagliflozin among patients with type 2 diabetes and cardiovascular risk.

October 31st 2024

Real-Time Pharmacist Feedback Improves Heart Failure Medication Management | AHA 2024

Lauren Biscaldi, MS, Managing Editor

Keeping the Focus on Community Pharmacy Advocacy at the State Level

Results of a study at the Veterans Health Administration found that feedback and education led to better medication outcomes for patients.

September 23rd 2024

Eating Problems, Diabetes Distress Associated with Worse Time-in-Range | AHA 2024

Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.

Over Half of US Population Concerned About Prescription Drug Access, Prices

Patients with type 2 diabetes who had eating problems and higher levels of diabetes distress had worse time-in-range.